原发性肝癌患者肝动脉化疗栓塞术前后血清TNFα、TGFβ1浓度变化及意义探讨

陆忠华; 邓俊; 杨小娟; 裴豪; 庄琳旎; 陈卫

原发性肝癌患者肝动脉化疗栓塞术前后血清TNFα、TGFβ1浓度变化及意义探讨

无锡市传染病医院

详细信息

中图分类号: R735.7
计量
- 文章访问数: 1990
- HTML全文浏览量: 12
- PDF下载量: 743
- 被引次数: 0
出版历程
- 出版日期: 2009-06-20

TNF α and TGF β1 in the serum of patients with primary hepatic cancer before and after transcatheter arterial chemoembolization

摘要

摘要: 目的观察原发性肝癌患者肝动脉化疗栓塞术(TACE)前后血清肿瘤坏死因子α(TNF浕)、转化生长因子β1(TGFβ1)的浓度变化。方法随机选择例确诊的原发性肝癌患者,用酶联免疫吸附试验法检测患者术前和术后两周血清肿瘤坏死因子α(TNFα)、转化生长因子β1(TGFβ1)的浓度变化。结果治疗后两周患者肿瘤坏死因子α(TNFα)、转化生长因子β1(TGFβ1)的浓度变化明显下降,与治疗前比较,差异有显著性意义(P<0.01)。结论血清肿瘤坏死因子、转化生长因子的浓度对TACE治疗原发性肝癌的预后观察具有一定的临床实用价值。
- 原发性肝癌 /
- 肝动脉化疗栓塞 /
- 肿瘤坏死因子α /
- 转化生长因子β1
Abstract: Objective To observe the change in the serum level of tumor necrosis factor alpha (TNF α) and transformation growth factor beta (TGF β1) in patients with primary hepatic carcinoma before and after the treatment with transcatheter hepatic arterial chemoembolization (TACE) Methods 30 primary hepatic cancer patients were randomly selected.The levels of TNF α and TGF β1 were measured by enzyme linked immune sorbent assay (ELISA) before and after treatment.Results the levels of TNF α and TGF β1 were decreased significantly after two weeks of treatment (p<0.01) .Conclusion Measurement of the levels TNF α and TGF β1 might have a significant clinical importance in the prognosis of primary hepatic carcinoma during TACE treatment.
- Primary hepatic cancer /
- Hranscatheter hepatic arterial chemoembolization /
- Tumor necrosis factor α /
- Transformation growth factor β1

HTML全文

参考文献(10)

[1]李欣, 冯敢生, 郑传胜, 等.肝动脉化疗栓塞对肿瘤血管生成影响的实验研究[J].中华放射学杂志, 2002, 36 (8) ∶689-693.

[2]Poon RT, Lau CP, Yu WC, et al.High serum levels of vascular en-dothelial growth factor predict poor response to transarterial chemoem-bolization in hepatocellular carcinoma a prospective study[J].Oncol Rep, 2004, 11 (5) ∶1077-1084.

[3]Kuo NT, Benhayon D, Przybylski RJ, et al.Prolonged hypoxia in-creases vascular endothelial growth factor mRNA and protein in adult mouse brain[J].J Appl Physiol, 1999, 86 (1) ∶260-264.

[4]孙惠川, 汤钊猷, 王鲁, 等.肝癌患者血清VEGF、sVCAM和bFGF浓度的研究与术后短期复发的相关性[J].肿瘤, 2001, 21 (6) ∶455-457.

[5]Imura S, Miyake H, Izumi K, et al.Corralation of vascular endothe-lia cell proliferation with microvessel density and expression of vascu-lar endothelial growth factor and basic fibroblast growth factor in hep-atocellular carcinoma[J].J Med Invest, 2004, 51 (3-4) ∶202-209.

[6]Zhou J, Tang ZY, Fan J, et al.Expression of platelet-derived en-dothelial cell growth factor and vascular endothelial growth factor in hepatocellular carcinoma and portal vein tumor thrombus[J].J Cancer Res Clin Oncol, 2000, 126 (1) ∶56-61.

[7]Mathonnet M, Descottes B, ValleixD, et al.Quantitative analysis u-sing ELISA of vascular endothelial growth factor and basic fibroblast growth factor in human colorectal cancer, liver metastasis of colorec-tal cancer and hepatocellular carcinoma[J].World J Gastroenterol, 2006, 12 (23) ∶3782-3783.

[8]Ji GZ, Wang XH, Miao L, et al.Role of transforming growth facter-betal-smad signal transduction pathway in patients with hepatocellu-lar carcinoma[J].World J Gastroenterol, 2006, 12 (4) ∶644-648.

[9]刘谨文, 易继林.经肝动脉化疗栓塞后TGFβ1、TGFα在肝癌细胞凋亡中的作用[J].临床外科杂志, 2000, 8 (6) ∶352-353.

[10]Sanchez-Elsner T, Botella LM, Velasco B, et al.Synergistic co-operation between hypoxia and transforming growth factor-βpath-ways on human vascular endothelial growth factor gene expression[J].J Biol Chem, 2001, 276 (42) ∶38527-38535.

施引文献

资源附件(0)

访问统计